🇺🇸 PCSK9 inhibitor plus statin in United States

PCSK9 inhibitor plus statin (PCSK9 inhibitor plus statin) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

PCSK9 inhibitor plus statin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is PCSK9 inhibitor plus statin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for PCSK9 inhibitor plus statin in United States?

Beijing Anzhen Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.